Company Xspray Pharma AB

Equities

XSPRAY

SE0009973563

Biotechnology & Medical Research

Delayed Nasdaq Stockholm 07:59:35 2024-03-28 am EDT 5-day change 1st Jan Change
42.1 SEK +0.24% Intraday chart for Xspray Pharma AB -1.86% +5.25%

Business Summary

XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments. The product candidates include Sprycel, also known as HyNap-Dasa, (version of dasatinib medicine), Tasigna, also under name HyNap-Nilo, (version of nilotinib medicine) and Nexavar, also is under name HyNap-Sora, (version of sorafenib medicine), among others. Sprycel and Tasigna are indicated for treatment of adult patients diagnosed with Philadelphia chromosome-positive (pH+) chronic myeloid leukemia (CML). Sprycel is also indicated for the treatment of adult patients with pH+ acute lymphocytic leukemia (ALL) and lymphoid blastic CML with resistance or intolerance to prior treatment. Nexavar is indicated for the treatment of patients with liver cell cancer, renal cell cancer and differentiated thyroid cancer.

Number of employees: 26

Managers

Managers TitleAgeSince
Chief Executive Officer 57 06-08-31
Director of Finance/CFO 52 Feb. 07
Chief Tech/Sci/R&D Officer - 22-08-31
Chief Tech/Sci/R&D Officer 60 17-12-31
Investor Relations Contact 63 19-05-14
Sales & Marketing - 22-03-14
Corporate Officer/Principal 75 09-12-31
Corporate Officer/Principal 55 23-09-14

Members of the board

Members of the board TitleAgeSince
Director/Board Member 71 14-12-31
Director/Board Member 68 14-12-31
Chairman 70 22-05-18
Director/Board Member 55 16-12-31
Director/Board Member 50 18-12-31
Director/Board Member 66 20-12-31
Director/Board Member 59 22-05-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 31,253,542 16,001,596 ( 51.20 %) 0 51.20 %

Shareholders

NameEquities%Valuation
4,027,091 12.89 % 16 M kr
Flerie Invest AB
11.08 %
3,464,378 11.08 % 14 M kr
Östersjöstiftelsen (Private Equity)
8.775 %
2,742,626 8.775 % 11 M kr
Fjärde AP-fonden
6.386 %
1,995,806 6.386 % 8 M kr
Teknik Innovation Norden Fonder AB
2.698 %
843,210 2.698 % 3 M kr
Unionen
2.579 %
806,000 2.579 % 3 M kr
Tredje AP-fonden
2.560 %
800,000 2.560 % 3 M kr
Andra AP-fonden
1.991 %
622,320 1.991 % 2 M kr
242,294 0.7753 % 945 998 kr
C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden)
0.7398 %
231,200 0.7398 % 902 683 kr

Company contact information

Xspray Pharma AB

Råsundavägen 12

169 67, Solna

+46 87 30 37 00

http://www.xspraypharma.com
address Xspray Pharma AB(XSPRAY)